Literature DB >> 21228106

microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles.

Kirti Bhatt1, Qing-Sheng Mi, Zheng Dong.   

Abstract

MicroRNAs (miRNA) are endogenously produced, short RNAs that repress and thus regulate the expression of almost half of known protein-coding genes. miRNA-mediated gene repression is an important regulatory mechanism to modulate fundamental cellular processes such as the cell cycle, growth, proliferation, phenotype, and death, which in turn have major influences on pathophysiological outcomes. In kidneys, miRNAs are indispensable for renal development and homeostasis. Emerging evidence has further pinpointed the pathogenic roles played by miRNAs in major renal diseases, including diabetic nephropathy, acute kidney injury, renal carcinoma, polycystic kidney disease, and others. Although the field of renal miRNA research is still in its infancy and important questions remain, future investigation on miRNA regulation in kidneys has the potential to revolutionize both the diagnosis and treatment of major renal diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228106      PMCID: PMC3064140          DOI: 10.1152/ajprenal.00727.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  96 in total

1.  Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1.

Authors:  Ellian Wang; Hsiu-Mei Hsieh-Li; Yuan-Yow Chiou; Yi-Lin Chien; Hua-Hui Ho; Hsian-Jean Chin; Chi-Kuang Leo Wang; San-Chi Liang; Si-Tse Jiang
Journal:  J Pathol       Date:  2010-11       Impact factor: 7.996

Review 2.  Genomic organization of microRNAs.

Authors:  Abigail F Olena; James G Patton
Journal:  J Cell Physiol       Date:  2010-03       Impact factor: 6.384

Review 3.  miRNAs as molecular biomarkers of cancer.

Authors:  Muller Fabbri
Journal:  Expert Rev Mol Diagn       Date:  2010-05       Impact factor: 5.225

4.  E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta.

Authors:  Bo Wang; Michal Herman-Edelstein; Philip Koh; Wendy Burns; Karin Jandeleit-Dahm; Anna Watson; Moin Saleem; Gregory J Goodall; Stephen M Twigg; Mark E Cooper; Phillip Kantharidis
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

Review 5.  Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.

Authors:  N Pabla; Z Dong
Journal:  Kidney Int       Date:  2008-02-13       Impact factor: 10.612

Review 6.  Chronic allograft nephropathy: what have we learned from protocol biopsies?

Authors:  Jean-Louis Bosmans; Dirk K Ysebaert; Gert A Verpooten
Journal:  Transplantation       Date:  2008-04-15       Impact factor: 4.939

7.  Microarray analysis of micro-ribonucleic acid expression in primary immunoglobulin A nephropathy.

Authors:  Yong Dai; Weiguo Sui; Huijuan Lan; Qiang Yan; He Huang; Yuanshuai Huang
Journal:  Saudi Med J       Date:  2008-10       Impact factor: 1.484

8.  MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease.

Authors:  Seung-Ok Lee; Tatyana Masyuk; Patrick Splinter; Jesús M Banales; Anatoliy Masyuk; Angela Stroope; Nicholas Larusso
Journal:  J Clin Invest       Date:  2008-10-23       Impact factor: 14.808

Review 9.  Riboregulators in kidney development and function.

Authors:  Dwi Setyowati Karolina; E M Wintour; John Bertram; Kandiah Jeyaseelan
Journal:  Biochimie       Date:  2009-12-31       Impact factor: 4.079

Review 10.  Small silencing RNAs: an expanding universe.

Authors:  Megha Ghildiyal; Phillip D Zamore
Journal:  Nat Rev Genet       Date:  2009-02       Impact factor: 53.242

View more
  81 in total

Review 1.  MicroRNAs in renal development.

Authors:  Jacqueline Ho; Jordan A Kreidberg
Journal:  Pediatr Nephrol       Date:  2012-06-02       Impact factor: 3.714

Review 2.  The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.

Authors:  Alison J Kriegel; Yong Liu; Yi Fang; Xiaoqiang Ding; Mingyu Liang
Journal:  Physiol Genomics       Date:  2012-01-03       Impact factor: 3.107

3.  The long and short of microRNAs in the kidney.

Authors:  Jacqueline Ho; Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

Review 4.  Klotho as a potential biomarker and therapy for acute kidney injury.

Authors:  Ming-Chang Hu; Orson W Moe
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

Review 5.  Anti-fibrosis therapy and diabetic nephropathy.

Authors:  Anil Karihaloo
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

6.  MicroRNA profiling identifies miR-129-5p as a regulator of EMT in tubular epithelial cells.

Authors:  Yanlin Li; Haiwen An; Jie Pang; Lin Huang; Jinshan Li; Linna Liu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 7.  Molecular mechanisms of ischemic preconditioning in the kidney.

Authors:  Pinelopi P Kapitsinou; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-26

Review 8.  Translational study of microRNAs and its application in kidney disease and hypertension research.

Authors:  Alison J Kriegel; Domagoj Mladinov; Mingyu Liang
Journal:  Clin Sci (Lond)       Date:  2012-05-01       Impact factor: 6.124

9.  MicroRNA-34a targets sirtuin 1 and leads to diabetes-induced testicular apoptotic cell death.

Authors:  Dan Jiao; Huan Zhang; Ziping Jiang; Wenlin Huang; Zhuo Liu; Zhaohui Wang; Yonggang Wang; Hao Wu
Journal:  J Mol Med (Berl)       Date:  2018-07-21       Impact factor: 4.599

Review 10.  Serum miRNAs as Biomarkers for the Diagnosis and Prognosis of Thyroid Cancer: A Comprehensive Review of the Literature.

Authors:  Mohammad-Reza Mahmoudian-Sani; Ameneh Mehri-Ghahfarrokhi; Majid Asadi-Samani; Gholam-Reza Mobini
Journal:  Eur Thyroid J       Date:  2017-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.